Skip to main content
. 2021 Feb 9;14(2):e003183. doi: 10.1161/CIRCGEN.120.003183

Figure.

Figure.

Manhattan plot for the genome-wide association study (GWAS) of gastrointestinal adverse events in COLCOT (Colchicine Cardiovascular Outcomes Trial) using Cox proportional hazards regression with 4 468 817 genetic variants of minor allele frequency ≥5% with 767 patients from the colchicine arm of COLCOT, controlling for age, sex, and principal components for genetic ancestry.